Comparative outcomes for tirzepatide versus glucagon-like peptide-1 receptor agonists in patients with inflammatory bowel disease: a national propensity matched study.

Mounjaro (tirzepatide) - Eli Lilly

http://www.ncbi.nlm.nih.gov/pubmed/42717572

Arun J Sanyal; Butros Fakhoury; Juan Pablo Arab; Kavin Parmar; Krishan S Patel; Raseen Tariq; Vinay Jahagirdar

Sep 11, 2026